Comparative Pharmacology
Head-to-head clinical analysis: PIPERAZINE CITRATE versus POVAN.
Peer-Reviewed Evidence
Head-to-head clinical analysis: PIPERAZINE CITRATE versus POVAN.
PIPERAZINE CITRATE vs POVAN
Comparing the clinical profiles, pharmacokinetic behaviors, and safety indices of these two therapeutic agents.
Piperazine citrate acts as a gamma-aminobutyric acid (GABA) receptor agonist in nematodes, causing hyperpolarization of nerve membranes and flaccid paralysis of the worm, which is then expelled by normal peristalsis. It does not affect mammalian neuromuscular junctions due to differences in GABA receptor sensitivity.
Pyrvinium pamoate inhibits oxidative metabolism and glucose uptake in susceptible helminths, leading to energy depletion and paralysis of the worm. It also binds to DNA and inhibits RNA synthesis in the parasite.
Adults: 3.5 g orally once daily for 2 days; may repeat after 1 week if needed.
Pyrantel pamoate: 11 mg/kg (maximum 1 g) orally once; repeat in 2 weeks for pinworm. For ascariasis, hookworm, trichostrongyliasis: 11 mg/kg (max 1 g) once daily for 3 days.
None Documented
None Documented
Terminal elimination half-life: 2-4 hours in patients with normal renal function; may be prolonged in renal impairment.
Terminal elimination half-life is approximately 16 hours; clinically, this supports single-dose administration with slow elimination
Primarily renal (60-70% unchanged); biliary/fecal elimination accounts for 10-20% of the dose.
Primarily fecal (90%) as unchanged drug via bile; renal excretion is minimal (<1%)
Category C
Category C
Anthelmintic
Anthelmintic